Clinical trial
Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To…
NCT00376038 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00376038 |
|---|---|
| Title | Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes |
| Official title | A Randomized Open-label, Repeat Dose, Two Sequence Cross-Over Study to Determine the Effect of GSK189075 on the Pharmacokinetic Parameters of Metformin (Glucophage) in Subjects With Type 2 Diabetes Mellitus. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | GSK189075 oral tablets, metformin tablets |
| Enrollment | 13 |
| Start date | Aug 1, 2006 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Sep 14, 2006 |
| Last update posted | Jun 4, 2012 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: